4//SEC Filing
Levitsky Hyam 4
Accession 0001062993-23-009200
CIK 0001850119other
Filed
Apr 13, 8:00 PM ET
Accepted
Apr 14, 7:56 PM ET
Size
5.2 KB
Accession
0001062993-23-009200
Insider Transaction Report
Form 4
Levitsky Hyam
President of R&D
Transactions
- Award
Stock Option (right to buy)
2023-04-12+131,250→ 131,250 totalExercise: $2.91Exp: 2033-04-12→ Common Stock (131,250 underlying)
Footnotes (1)
- [F1]The option vests 25% on April 12, 2024, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.
Issuer
Century Therapeutics, Inc.
CIK 0001850119
Entity typeother
Related Parties
1- filerCIK 0001375792
Filing Metadata
- Form type
- 4
- Filed
- Apr 13, 8:00 PM ET
- Accepted
- Apr 14, 7:56 PM ET
- Size
- 5.2 KB